Iasis Molecular Science

IMS has pioneered and patented technologies aimed at preventing medical device infections and treating and preventing infections associated with complex wounds. We have also developed performance coatings for various applications including decorative paints, industrial flooring and marine anti-fouling paints. Iasis Molecular Sciences is on a path to providing value added, life improving solutions to treat or mitigate infections and performance coating solutions to enhance many human-environment interactions. IMS was founded following the discovery that sodium polystyrene sulfonate, a water soluble polymer similar to the FDA-approved therapy Kaexalate, could be used to bind and release antiseptics and provide anti-inflammatory benefits for the treatments of wounds. Later, the concept of using polysulfonates as a delivery platform was leveraged to create a family of formulation modifiers with the ability to render surfaces self-disinfecting.